Novartis has spent considerable time and energy building its presence in the IgA nephropathy (IgAN) disease area, and now | ...

Perth-based biotech Argenica Therapeutics, which is developing treatments to reduce brain tissue death after stroke, plans to ...

Auxora has been assessed in efficacy trials including the Phase IIb CARPO trial for SIRS and acute pancreatitis.

UEFA Technical Observer Joe Montemurro highlights Manchester United's defensive mettle in their Matchday 2 victory over ...

Ozak AI’s presale is already booming in the crypto industry. Many investors and whales have started transferring their money ...

IFSC Grade A Exam Analysis 2025 with Phase 1 concluded with moderate difficulty. Paper 1 doable, Paper 2 moderate to tough.

NMPA’s response is based on the Phase 3 DRAGON interim analysis resultsTopline final data expected in Q4 2025 SAN DIEGO, Oct. 15, 2025 (GLOBE NEWSWIRE) -- Belite Bio, Inc. (NASDAQ: BLTE), a ...

Final data analysis from the Dimerix collaboration with PARASOL reinforces the company’s proteinuria-based endpoints in its phase III ACTION3 trial of lead drug DMX-200 in rare kidney disease Focal ...

Advances in mass spectrometry and chromatography are enhancing pesticide residue analysis, focusing on exposomics and risk assessment for improved food safety. Ion chromatography is evolving with new ...

The Gaza ceasefire agreement was mediated by the United States along with Egypt, Qatar and Turkey. Its second phase calls for ...

Tvardi Therapeutics' shares crater after its phase II idiopathic pulmonary fibrosis study shows no meaningful benefit from TTI-101 therapy compared to placebo.

The achievement of a ceasefire in Gaza has earned Trump praise from across the political aisle and from U.S. friends and foes ...